Independent US Healthcare Provider Directory & Public Medical Database Patient Guides
T-MedInfo US Healthcare Directory

Dr. Brian Jeffery Williams , MD

Dermatology • Midvale, UT

Active NPI 1235162199 Individual Practitioner Male Practitioner Accepts Medicare assignment
Practice location in NPPES

602 Fort Union Blvd, 2nd Floor
Midvale, UT 840472216

Call 8013131010 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

602 Fort Union Blvd
2nd Floor

Midvale, UT 840472216

Telephone 8013131010
Fax 8017472116
Before You Book

Paying without insurance? Prepare a cost-estimate request

Ask about interpreters and office accessibility

Organization at the Same NPPES Address or Phone
Brian J Williams Md Pc Facility NPI 1255502050

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File

Medical School

University Of Utah School Of Medicine

Graduation Year

1999

What Public CMS Data Show

These CMS figures cover limited populations and published records; they are not quality ratings or medical advice.

Dermatology: NPPES taxonomy is a reported classification, not proof of board certification.

Medicare patients

638 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

It gives a sense of how many people with Medicare this clinician treated that year.

Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.

Medicare-allowed amount

About $75,375 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

Paid by Medicare

About $48,700 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

The gap between the allowed amount and this number is roughly what patients and their other insurance paid.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

30-day fills

1,310 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$37,081 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

It shows the total spending on drugs this clinician prescribed, not what any one patient paid.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $307,732.86 across 400 records.

By nature of payment (3 largest of 5)

  • Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $246,268.50 across 83 records.
  • Honoraria: $30,600.00 across 11 records.
  • Travel and Lodging: $16,289.21 across 138 records.

Reporting-company totals (3 largest of 14)

  • Galderma Laboratories, L.P.: $104,515.28 across 100 records.
  • UCB, Inc.: $77,574.30 across 94 records.
  • Eli Lilly and Company: $58,738.75 across 75 records.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

27 years (graduated 1999)

CMS Doctors and Clinicians data list 1999 as the year this clinician finished professional school.

It tells you roughly how long ago the clinician finished school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File.

NPI first issued

2006

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

No telehealth indicator

CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Williams has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Williams as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

Medicare pays for these items and services only when they are ordered by an eligible clinician.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Midvale and Utah

Billing and prescribing volume is not a quality rating.

Medicare Part B services

Fewer Medicare Part B services than 65% of clinicians listed under Dermatology in Utah (2024, 123 clinicians with data). Median for this group: 1,861. Middle half: 953 to 4,077.

Too few clinicians listed under Dermatology in Midvale have Medicare Part B data for 2024 to compare.

Medicare-allowed amount

A lower Medicare-allowed amount than 60% of clinicians listed under Dermatology in Utah (2024, 123 clinicians with data). Median for this group: $105,609. Middle half: $50,802 to $207,855.

Too few clinicians listed under Dermatology in Midvale have Medicare Part B data for 2024 to compare.

Paid by Medicare

A lower Medicare payment amount than 65% of clinicians listed under Dermatology in Utah (2024, 123 clinicians with data). Median for this group: $74,322. Middle half: $33,246 to $144,157.

Too few clinicians listed under Dermatology in Midvale have Medicare Part B data for 2024 to compare.

Medicare Part D prescriptions

More Part D prescriptions than 95% of clinicians listed under Dermatology in Utah (2024, 128 clinicians with data). Median for this group: 373. Middle half: 170 to 679.

Too few clinicians listed under Dermatology in Midvale have Medicare Part D data for 2024 to compare.

Part D drug cost

A higher Part D drug cost than 60% of clinicians listed under Dermatology in Utah (2024, 128 clinicians with data). Median for this group: $13,021. Middle half: $3,904 to $112,079.

Too few clinicians listed under Dermatology in Midvale have Medicare Part D data for 2024 to compare.

2 active clinicians are listed under Dermatology with a practice address in Midvale, UT (179 in Utah).

Addresses are self-reported to NPPES and may be out of date.

CMS data by year

Changes may reflect reporting, coverage or privacy limits, not changes in care quality.

  • Medicare Part B services

    Medicare Part B services decreased 31% from 1,590 in 2020 to 1,090 in 2024.

    • 2020: 1,590
    • 2021: 2,044
    • 2022: 1,977
    • 2023: 2,042
    • 2024: 1,090

  • Medicare-allowed amount

    Medicare-allowed amount decreased 33% from $112,249 in 2020 to $75,375 in 2024.

    • 2020: $112,249
    • 2021: $150,410
    • 2022: $140,253
    • 2023: $140,441
    • 2024: $75,375

  • Paid by Medicare

    Paid by Medicare decreased 30% from $69,211 in 2020 to $48,700 in 2024.

    • 2020: $69,211
    • 2021: $95,537
    • 2022: $86,000
    • 2023: $89,082
    • 2024: $48,700

  • Medicare Part D prescriptions

    Medicare Part D prescriptions increased 46% from 766 in 2020 to 1,117 in 2024.

    • 2020: 766
    • 2021: 801
    • 2022: 859
    • 2023: 1,001
    • 2024: 1,117

  • 30-day fills

    30-day fills increased 56% from 840 in 2020 to 1,310 in 2024.

    • 2020: 840
    • 2021: 870
    • 2022: 954
    • 2023: 1,155
    • 2024: 1,310

  • Part D drug cost

    Part D drug cost varied from year to year: $36,707 in 2020 and $37,081 in 2024.

    • 2020: $36,707
    • 2021: $35,505
    • 2022: $34,092
    • 2023: $130,652
    • 2024: $37,081

  • Industry payments (Open Payments)

    Industry payments (Open Payments) increased 825% from $33,256.78 in 2021 to $307,732.86 in 2025.

    • 2021: $33,256.78
    • 2022: $76,640.49
    • 2023: $162,091.98
    • 2024: $178,239.16
    • 2025: $307,732.86

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo · Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments · Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 – December 31, 2025): 400 records totaling $307,732.86.

Manufacturer Payment Nature Product Type Amount ($)
Galderma Laboratories, L.P.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
 NEMLUVIO General $9,300.00
Galderma Laboratories, L.P.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
 — General $9,300.00
Galderma Laboratories, L.P.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
 NEMLUVIO General $9,300.00
Galderma Laboratories, L.P.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
 NEMLUVIO General $8,100.00
UCB, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
 Bimzelx General $6,500.00
UCB, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
 Bimzelx General $6,500.00
UCB, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
 Bimzelx General $6,500.00
UCB, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
 Bimzelx General $6,500.00
UCB, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
 Bimzelx General $6,500.00
Incyte Corporation
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
 Opzelura General $5,700.00
Galderma Laboratories, L.P.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
 NEMLUVIO General $5,400.00
Organon LLC
Honoraria
Cash or cash equivalent
 VTAMA General $5,400.00
Galderma Laboratories, L.P.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
 NEMLUVIO General $5,400.00
UCB, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
 Bimzelx General $5,000.00
LEO Pharma Inc.
Consulting Fee
Cash or cash equivalent
 ANZUPGO General $4,613.00
UCB, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
 Bimzelx General $4,000.00
UCB, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
 Bimzelx General $4,000.00
UCB, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
 Bimzelx General $4,000.00
UCB, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
 Bimzelx General $4,000.00
Eli Lilly and Company
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
 EBGLYSS General $4,000.00
UCB, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
 Bimzelx General $4,000.00
UCB, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
 Bimzelx General $4,000.00
UCB, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
 Bimzelx General $3,864.00
UCB, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
 Bimzelx General $3,864.00
Galderma Laboratories, L.P.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
 NEMLUVIO General $3,600.00

(top 25 shown)

Source: CMS Open Payments, program year 2025, released June 30, 2026.

A reported payment does not necessarily indicate wrongdoing; clinicians can dispute a record with CMS.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B · Data Year 2024
Reporting Year:

CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
397 355 $125.00 $52.71
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
246 207 $144.00 $85.01
11102 Biopsy of related skin growth, first growth
110 106 $230.00 $91.78
17000 Destruction of precancer skin growth, 1 growth
80 76 $165.00 $58.87
17003 Destruction of precancer skin growth, 2-14 growths
65 39 $25.50 $6.10
99202 New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more
42 42 $178.00 $67.24
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
30 30 $205.00 $104.15
11103 Biopsy of related skin growth, each additional growth
27 16 $146.00 $46.17
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
24 17 $362.00 $130.53
11104 Punch biopsy, first skin growth
20 19 $216.00 $115.19
17261 Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm
19 18 $291.00 $122.36
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
16 15 $225.00 $119.48
17110 Destruction of skin growth, 1-14 growths
14 12 $199.00 $104.73

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D · Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Ketoconazole Ketoconazole 155 4,837 $2,052.28 83
Fluorouracil Fluorouracil 146 4,155 $10,337.21 132
Triamcinolone Acetonide Triamcinolone Acetonide 142 3,677 $1,148.96 109
Betamethasone Dipropionate Betamethasone Dipropionate 87 2,152 $3,820.85 58
Tacrolimus Tacrolimus 85 2,517 $8,082.87 58
Minoxidil Minoxidil 65 3,130 $612.79 17
Clindamycin Phosphate Clindamycin Phosphate 54 1,533 $1,376.64 23
Econazole Nitrate Econazole Nitrate 54 1,200 $1,257.67 42
Doxycycline Hyclate Doxycycline Hyclate 47 1,940 $1,351.60 32
Cephalexin Cephalexin 43 352 $407.77 42
Terbinafine Hcl Terbinafine Hcl 40 2,364 $589.36 30
Fluocinolone Acetonide Fluocinolone/Shower Cap 33 916 $1,877.42 31
Mupirocin Mupirocin 31 465 $242.88 24
Finasteride Finasteride 23 1,640 $131.10 —
Fluocinonide Fluocinonide 22 800 $650.62 13
Famciclovir Famciclovir 19 154 $456.08 17
Metronidazole Metronidazole 17 574 $921.83 14
Hydrocortisone Hydrocortisone 16 307 $98.80 13
Tretinoin Tretinoin 14 460 $1,336.29 —
Imiquimod Imiquimod 13 368 $296.96 12
Prednisone Prednisone 11 90 $31.29 11

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Dermatology Primary Specialty

NUCC Taxonomy Code: 207N00000X

License # reported to NPPES UT 5322538-1205

A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Utah Division of Professional Licensing.
Look Up on State Board Site

Additional State Medicaid & Healthcare Payer Identifiers

Medicaid ID
1235162199 (UT)
Other Identifier Medicaid License Number
D5439 (UT)

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - DERMATOLOGY

Medicare Enrollment ID

I20041123000347

Enrollment State Jurisdiction

UT

PECOS Control ID

3870558521

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

2 listed
Joanna Kennedy

Nurse Practitioner - Family

NPI 1871031708
Stacie Pearce , NP

Nurse Practitioner - Family

NPI 1912207226

Nurse Practitioner

Career & Practice History

NPI enumerated July 07, 2006.

No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1235162199
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: July 07, 2006
Last Update: December 09, 2009
Sole Proprietor: No
Update or Correct Profile

Mailing Address

602 Fort Union Blvd, 2nd Floor

Midvale, UT 840472216

Phone: 8013131010

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.